Fresh analysis indicates that patients who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro can put back on lost weight much more quickly than those who stop conventional diet and exercise programs.
Research printed in a prominent health publication points out that while obese people often shed substantial amounts of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"Users using such drugs need to be cognizant of the risk of rapid rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment weight within about a year and a half.
Analyzing Therapies
The research, which reviewed dozens of studies involving thousands of patients, compared the outcomes of these new drugs with other pills.
Researchers note that people who shed pounds through lifestyle changes alone generally have a slower creep back—approximately 100 grams monthly—after stopping.
The Reason for the Fast Regain
Nutrition scientists believe the mode of action of the jabs is key to understanding the heightened weight return.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing the hormone levels far above than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' results in hunger is unsuppressed, making overeating far more likely."
An Ongoing Disease?
Health authorities advise the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
A number of clinicians argue that, due to the significant potential of relapse, the therapy might need to be life-long.
This view is supported by drug manufacturers, who state that the findings "emphasize the persistent character of obesity," comparing it to managing diseases like diabetes.
User Testimonies
Users who have come off the jabs explain a powerful return of appetite.
"I experienced a trigger flipping and you're instantly ravenous," said one woman.
The struggle is exacerbated if users have not adopted lasting dietary or behavioural modifications during therapy.
Widespread Use
Survey data indicate that millions of people in the UK have used these injections in the last 12 months, with desire remaining high.
- Adoption is greater among women compared to males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while the jabs are effective tools for weight loss, they are not a standalone fix and lasting health benefits likely depends on ongoing behavioural management.